This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Sep;15(10):e415-6.

doi: 10.1016/S1470-2045(14)70337-7.

MRD stratification for paediatric ALL

Chris Mitchell¹, Nick Goulden², Ajay Vora³

Affiliations

Affiliations

¹ John Radcliffe Hospital, Oxford, UK.
² Great Ormond Street Hospital, London, UK.
³ Sheffield Children's Hospital, Department of Paediatric Haematology, Western Bank, Sheffield, South Yorkshire S10 2TH, UK. Electronic address: ajay.vora@sch.nhs.uk.

PMID: 25186043
DOI: 10.1016/S1470-2045(14)70337-7

Comment

MRD stratification for paediatric ALL

Chris Mitchell et al. Lancet Oncol. 2014 Sep.

. 2014 Sep;15(10):e415-6.

doi: 10.1016/S1470-2045(14)70337-7.

Authors

Chris Mitchell¹, Nick Goulden², Ajay Vora³

Affiliations

¹ John Radcliffe Hospital, Oxford, UK.
² Great Ormond Street Hospital, London, UK.
³ Sheffield Children's Hospital, Department of Paediatric Haematology, Western Bank, Sheffield, South Yorkshire S10 2TH, UK. Electronic address: ajay.vora@sch.nhs.uk.

PMID: 25186043
DOI: 10.1016/S1470-2045(14)70337-7

No abstract available

PubMed Disclaimer

Comment on

Acting on minimal residual disease in ALL.
Rytting M. Rytting M. Lancet Oncol. 2014 Jul;15(8):777-8. doi: 10.1016/S1470-2045(14)70280-3. Epub 2014 Jun 9. Lancet Oncol. 2014. PMID: 24924992 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

G0300130/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations